Submissions for an Australian Senate inquiry into current patient access barriers to medicinal cannabis close today.
Announced in November 2019, the wide-ranging inquiry is delving into issues including the appropriateness of the current regulatory regime, delays in accessing products and will also examine international best practice models for patient access.
At the time of writing, eleven submissions had been noted; including from:
Northern Territory Government
Multiple Sclerosis Research Australia and Multiple Sclerosis Australia
United in Compassion
Medical Cannabis Users Association of Australia (MCUA)
The (brief) submission from the NT Government revealed an interesting and disturbing fact:
“Uptake has been slow within the NT with only one prescription dispensed for a Schedule 8 medicinal cannabis product since the change in legislation,” the submission states.
However, it notes the NT Department of Health is aware of “a number” of other residents of the Territory accessing medicinal cannabis products via interstate specialists. The NT has a population of around 246,000.
United in Compassion,…